Skip to main content

Advertisement

ADVERTISEMENT

Commentary

mark munger, pharmd
Commentary
06/07/2021
Mark Munger, PharmD, reviews recent research that examined the effectiveness and safety of DOACs compared to warfarin in patients with valvular atrial fibrillation and provides insight for selecting the correct treatment regimen for this...
Mark Munger, PharmD, reviews recent research that examined the effectiveness and safety of DOACs compared to warfarin in patients with valvular atrial fibrillation and provides insight for selecting the correct treatment regimen for this...
Mark Munger, PharmD, reviews...
06/07/2021
Pharmacy Learning Network
Commentary
06/07/2021
In a past Talking Therapeutics column, Dr Jennings opined the nephroprotective effects of SGL2 inhibitors for patients with CKD. In this week’s column, he continues the kidney-focused theme with an exposé on finerenone—a novel, highly...
In a past Talking Therapeutics column, Dr Jennings opined the nephroprotective effects of SGL2 inhibitors for patients with CKD. In this week’s column, he continues the kidney-focused theme with an exposé on finerenone—a novel, highly...
In a past Talking Therapeutics...
06/07/2021
Pharmacy Learning Network
Headshot of Mark Munger, PharmD
Commentary
06/01/2021
Mark Munger, PharmD, provides up-to-date information on heart failure across the world, related mortality in rural versus urban adults, ethnic disparities in US outcomes, and potential innovations of heart failure care.
Mark Munger, PharmD, provides up-to-date information on heart failure across the world, related mortality in rural versus urban adults, ethnic disparities in US outcomes, and potential innovations of heart failure care.
Mark Munger, PharmD, provides...
06/01/2021
Pharmacy Learning Network

Advertisement

Commentary
05/18/2021
Yvette C Terrie, BS Pharm, RPh, consultant pharmacist, recently interviewed a third-year pharmacy student who shares insight on how the COVID-19 pandemic altered the pharmacy school education, and offers her own well wishes to the many...
Yvette C Terrie, BS Pharm, RPh, consultant pharmacist, recently interviewed a third-year pharmacy student who shares insight on how the COVID-19 pandemic altered the pharmacy school education, and offers her own well wishes to the many...
Yvette C Terrie, BS Pharm, RPh,...
05/18/2021
Pharmacy Learning Network
Pharmacy Law: Ohio House Passes Bill Increasing Emergency Prescription Refills
Commentary
05/13/2021
Ann Latner, JD, reviews a recent bill passed by the Ohio House of Representatives that increases the number of times a pharmacist can dispense a life-saving medication without a prescription in a year.
Ann Latner, JD, reviews a recent bill passed by the Ohio House of Representatives that increases the number of times a pharmacist can dispense a life-saving medication without a prescription in a year.
Ann Latner, JD, reviews a recent...
05/13/2021
Pharmacy Learning Network
Commentary
05/10/2021
Jill Paslier, PharmD, CSP, international safe medication management fellow, Institute for Safe Medication Practices, explains why pharmacy staff should approach all patient reporting errors or potential medication errors with transparency and...
Jill Paslier, PharmD, CSP, international safe medication management fellow, Institute for Safe Medication Practices, explains why pharmacy staff should approach all patient reporting errors or potential medication errors with transparency and...
Jill Paslier, PharmD, CSP,...
05/10/2021
Pharmacy Learning Network

Advertisement

Soumya Vishwanath, PharmD
Commentary
05/06/2021
Soumya Vishwanath, PharmD, University of Massachusetts Medical School, discusses digital therapeutics, which she says is the next wave of patient care, and highlights why it’s essential to assess how these products may play a role in clinical...
Soumya Vishwanath, PharmD, University of Massachusetts Medical School, discusses digital therapeutics, which she says is the next wave of patient care, and highlights why it’s essential to assess how these products may play a role in clinical...
Soumya Vishwanath, PharmD,...
05/06/2021
Pharmacy Learning Network
Save Those Kidney Beans: Nephro-Protective Effects of SGLT2 Inhibitors
Commentary
05/05/2021
In this week’s issue of Talking Therapeutics, Dr Jennings explores a new drug approval and what it means for patients with chronic kidney disease.
In this week’s issue of Talking Therapeutics, Dr Jennings explores a new drug approval and what it means for patients with chronic kidney disease.
In this week’s issue of Talking...
05/05/2021
Pharmacy Learning Network
Hypertension, Hyperlipidemia for Developing and Sustaining Atrial Fibrillation
Commentary
05/04/2021
“Goal-directed use of antihypertensives and statin drugs appear to be effective strategies to reduce atrial fibrillation incidence, morbidity, and mortality,” says Mark Munger, PharmD.
“Goal-directed use of antihypertensives and statin drugs appear to be effective strategies to reduce atrial fibrillation incidence, morbidity, and mortality,” says Mark Munger, PharmD.
“Goal-directed use of...
05/04/2021
Pharmacy Learning Network

Advertisement

Commentary
04/20/2021
“Health care providers can be instrumental in recognizing and helping patients suffering with mental health issues by keeping the lines of communication open and providing patients with encouragement and support,” says Yvette C Terrie, BS...
“Health care providers can be instrumental in recognizing and helping patients suffering with mental health issues by keeping the lines of communication open and providing patients with encouragement and support,” says Yvette C Terrie, BS...
“Health care providers can be...
04/20/2021
Pharmacy Learning Network